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Research approaches to improve outcome of sensori-motor functions after a spinal cord injury 
(SCI) concern first, experimental therapies that enhance neuronal and tissue repair in animals; 
some of these approaches are on the way to translation into clinical trials. A second line of 
research is based on the enhancement of neuroplasticity by a functional training being a main (and 
also classical) driver to improve outcome of function after SCI. This research is based on both, 
basic research in animals, especially rodents, as well as in human beings. In the last 30 years, 
animal and human research made several important discoveries, creating insights and concepts 
that greatly have advanced the field. However, not all problems are solved yet, and novel ones also 
arose.  The focus of this opinion paper will be on the actual promises and challenges for the 
translation of new concepts and therapeutic approaches from the rodent SCI model to the 
application in human SCI. 
 
Basic research in animals  
 Animal models are central to our understanding of the pathophysiology and the repair processes 
after SCI. Central topics over the last 30 years were the characterization of growth inhibitory and 
growth promoting factors in the central nervous system (CNS) tissue, the restricted neuronal 
growth capacity of adult CNS neurons, inflammatory reactions at lesion sites, scar formation, 
neuroprotection and attempts to bridge the lesion, as well as myelin repair. Stimulation of the 
spinal cord combined with the application of dopaminergic drugs and an intense training was 
another approach, based on the inherent, activity-enhanced plasticity of neuronal circuits within 
the spinal cord below the lesion. Anatomical, physiological and behavioral read-outs were used. 
Several approaches showed promising results in particular in terms of an improved functional 
outcome. For a few of these experimental therapies, clinical trials in spinal cord injured patients 
are currently on-going or planned.  
The following promises and challenges arise in the translation from bench to bedside: 
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Promises 
 
- The discovery of specific growth inhibitory factors in the adult CNS, in particular the myelin 
enriched membrane protein Nogo-A as well as the scar and perineuronal net associated 
chondroitin sulfate proteoglycans, triggered experiments where these factors were neutralized (e.g. 
by antibodies), destroyed (e.g. by chondroitinase), genetically deleted or down knocked, or 
inactivated by interfering with their receptors or downstream intracellular signaling pathways (for 
reviews).
1
 
2
 
3
 In many studies from different laboratories, enhanced neuritic sprouting was seen 
from lesioned (regenerative sprouting) as well as spared (compensatory sprouting) fibers in the 
damaged spinal cord and brain. Long distance regeneration of small proportions of fibers through 
remaining tissue bridges was also reproducibly observed. Anti-Nogo-A antibody therapy is in 
clinical trials at present for SCI, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). 
The second messenger RhoA blocker Cethrin/VX210, which shows a similar effect profile, is also 
in Phase II trials at present. 
 
- Enhancement of neurite growth and regeneration can be induced on the neuronal level by 
stimulating the mTOR pathway (e.g. by suppression of its inhibitor Phosphatase and tensin 
homolog PTEN, stimulation of the cytokine signaling pathway, or the cAMP pathway.
4, 5
 The 
functional consequence of this growth stimulation in the spinal cord is not well known yet. In the 
crushed optic nerve, however, regeneration of a few fibers up to the pretectum and superior 
colliculus with the restoration of light responses was reported.
6
 No clinical trials were started yet 
using these approaches. 
 
-The stabilization of the axonal cytoskeleton, in particular the microtubules was recently shown to 
significantly enhance regenerative tract sprouting and growth in the injured rodent spinal cord.
7, 8
 
Interestingly, quite low concentrations of Taxol or epothiloneB exert these effects in vitro and in 
vivo, conditions that could be readily translated into clinical tests. 
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-Bridging the lesion site by cellular transplants has been tried over many years with variable 
success. Implanted materials often get walled off by scarring astrocytes, but Schwann cells,
9
 
peripheral nerve grafts 
10
 or olfactory ensheathing cells 
11
 can integrate into the spinal cord tissue 
and form bridges for regenerating axons. The exact conditions for reproducible bridge formation 
are not well known, and the variability in these experiments between labs and publications is high. 
Injections of autologous olfactory ensheathing cells (OEC) were tried in chronic human SCI. 
Neither negative nor beneficial effects were found in individuals with motor complete SCI.
12
 Also 
results from a larger group of individuals examined in China did not show signs of motor recovery 
(cf.
13
) On the other hand, a single case with positive effects of these transplanted cells was 
recently reported in a Polish study.
14
 
During last years the most successful bridging study consisted of a combination of multiple 
peripheral nerve grafts with fibrin glue, neural stem cells (with a strong growth potential), and a 
neurotrophic growth factor.
15
 Serotoneric axons grew through these bridges and reinnervated 
adjacent spinal cord segments. While stem cell derived axons reached the lower spinal cord as 
well as the brain, the functional (or malfunctional) role of these fibers remains unclear up to now.  
 
-Injections of heterologous cells of a neural stem cell line were recently done in a Phase I clinical 
study in Zurich in a limited number of SCI patients. No treatment-associated adverse events were 
seen and some of the patients showed segmental extension of sensory functions below the injury 
site. A Phase II multicentric clinical trial is currently on the way in the US. Mechanistically, 
modulatory effects of stem cell derived factors on inflammatory, immune, scarring and 
neuroprotective processes might be expected. Furthermore, the generation of oligodendrocytes and 
the formation of new myelin might derive from the stem cells. On the basis of observations in 
animal models  a differentiation into neurons might also occur which could form relay neuronal 
circuits between cut descending fibers and the lower or upper spinal cord.
16, 17
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-Training experiments performed originally in spinal transected cats showed that regular stepping 
as well as standing can be trained in the lumbar spinal cord completely separated from the brain.
18, 
19
 The underlying concept was that the locomotor pattern generator within the lumbar spinal cord 
becomes activated by external stimuli.
20
 In the early nineties, this locomotor training approach was 
successfully translated to spinal cord injured humans.
21, 22
 Training-induced locomotor activity 
could be demonstrated even in patients with a complete SCI.
23
 Treadmill training, assisted 
manually by physiotherapists or by robots, is now part of routine rehabilitation programs in many 
SCI rehabilitation centers. Thus this training approach represents a typical example of highly 
successful clinical translation of findings and concepts from basic science. 
 
 -Direct epidural stimulation of the lumbar spinal cord, sometimes in combination with intrathecal 
drug administration of serotonergic and/or dopaminergic agonists, results in enhanced mobility on 
treadmills in the rodent SCI model.
24-26
 This combined approach is still in an experimental stage. 
Interestingly, clonidine was shown to improve walking ability in the cat with a transected spinal 
cord,
27
. Its intrathecal application in human SCI resulted in incomplete injury in inconsistent 
effects
28
 ,in complete injury in a flaccid paresis.
21
 . 
 
-The stimulation part of this approach was recently translated to human SCI with interesting 
results.
29, 30
 A combination of intense training and epidural spinal cord stimulation allowed motor 
complete SCI patients the performance of small voluntarily controlled foot and leg movements, as 
well as improved standing (however not stepping movements). The approach is limited to severely 
injured, paralysed SCI patients who have some spared axons running through the damaged part of 
the spinal cord. Thus, in these patients stimulation elevates the excitability of spinal neuronal 
circuits, or of spared descending connections to a level wheresome neuronal circuits can function 
and ‘voluntary’ commands can become minimally effective. How generally applicable these 
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therapeutic interventions will be and what their benefit for the daily life of patients could be, will 
be seen in the future once a larger number of SCI patients have been treated.  
 
Challenges 
- The functional read-outs in animal SCI models usually focus on the recovery of sensori-motor 
functions following an intervention. According to a query in SCI patients,
31
 these functions have 
lower priority for humans suffering an SCI; highest priorities are given to bladder control and 
sexual functions. Only a few research groups work on adequate models for these functions at 
present.
32-34
 A better understanding leading to good animal models and read-outs of e.g. bladder 
dysreflexia, blood pressure dysregulation and the connectivity underlying sexual functions is 
urgently needed. 
 
- Most interventions use thoracic lesions in rodent models with the aim to induce recovery of 
hindlimb locomotor function. For tetraplegic/quadriplegic, i.e. cervical spinal cord injured, 
patients with their loss of independence and quality of life, successful interventions to improve 
hand function and breathing would be of utmost importance. Cervical injuries are complicated by 
the fact of a combined damage of central and peripheral nervous structures (i.e. motoneurons and 
spinal roots), the latter contributes to up to 50% of paresis 
35
 (for review see.
36
) The rare use of 
cervical injury models in animals, in particular when applying large lesions, is also related to 
ethical issues and the difficulty to keep these animals in a good overall health status. 
 
-In a large number of animal studies, the lesions used are transections, - which are rare in human 
SCI patients. The typical lesion in humans is a contusion, sometimes a laceration, extending over 
2 to 3 segments, with bleedings and necrosis. Cysts and scars also form after transections, but the 
lesions are better defined and less variable, - which is the main reason why basic researchers 
usually prefer them and why weight drop contusions are rarely in use.  
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-  
-Many interventions, such as the growth promoting Nogo antibodies or mTOR manipulations 
require preserved tissue bridges at the lesion site to allow axonal regeneration through the 
damaged part of the spinal cord. Such bridges are present in all incomplete SCI patients, but, 
interestingly, also in some clinically complete SCI patients.  
 
- Description of the lesion extent, in particular also with regard to spared parts of the white matter 
and of specific tracts, is often performed in animal studies (based mostly on postmortem 
histology), but is almost impossible in SCI patients (however see Cohen-Adad and Wheeler-
Kingshott 2014 
37
). This is due to the difficulty to image patients with long imaging time protocols 
early after the accident, and the presence of metal implants as soon as the spinal cord is surgically 
stabilized. In addition, tracing and reconstruction of specific axonal tracts is routine in many 
animal studies, but missing with the current imaging technology in humans. 
 
-For some important sequels of a human SCI such as spastic movement disorder or neurogenic 
pain no adequate animal model exists. Spinal shock, which last for 4-6 weeks in acute SCI 
patients, is only short and less pronounced in animals. Muscle spasms develop in SCI rats, but 
reflect cramps rather than spastic muscle tone and are not yet well studied.
38
 
 
- In rodent models, therapeutic interventions are applied usually early or immediately after the 
spinal cord lesion. In acute human traumatic SCI, life saving treatments have the highest priority. 
Furthermore, for clinical trials the intervention has to be approved by the patient in a full 
conscious state. Therefore, a novel experimental intervention can hardly be applied earlier than 2 
to 3 weeks after trauma. Such a delay could be a critical factor responsible for differences seen in 
the effects of an intervention when comparing animal models and human SCI.   
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Clinical problems requiring basic animal research 
Basic animal research is not only needed to promote the progress in the field of regeneration. 
Clinical researchers also require basic animal research to answer important questions arising from 
clinical observations in neurorehabilitation. For example: 
-During locomotor training of chronic motor complete SCI subjects an exhaustion of leg muscle 
and spinal motoneuron activity occurs.
39
 Why does this dysfunction of neuronal spinal circuits 
below the level of lesion in SCI patients develop? There are rodent studies indicating an 
undirected neuroplasticity as a possible mechanism.
40
 In which way can this neuronal dysfunction 
be avoided or inversed? The proper functioning of neuronal circuits below the level of lesion is the 
prerequisite for a successful regeneration. 
 
-Neuroplasticity is supposed to be the neuronal substrate for the effects of functional training 
during neurorehabiliation. Its elements, - fiber growth and formation of new neuronal circuits, 
activation of ‘silent connections’, strengthening of pre-existing synapses, - need to be dissected. A 
key question is in which way these processes can be influenced and what roles are played by 
inflammatory and degenerating processes on the one hand, and training-induced neuronal activity 
on the other one. What are the individual limitations of neuroplasticity for an improved outcome? 
 
-The newly discovered mechanism of neural coupling as manifested in cooperative hand 
movements 
41
 should be modelled in animals to investigate the underlying neuronal circuitries. 
This could help to optimize their responses to training of hand function and to experimental 
interventions in tetraplegic patients. 
- The exploration of pain mechanisms should lead to measures that help to avoid the development 
of neurogenic pain and find a causal treatment of pain following an SCI.
42
 
 
Basic research in humans  
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Translational research concerns not only the translation of concepts and therapies from animal 
models to human conditions. Basic research performed in humans frequently also serves as the 
basis for novel rehabilitation approaches in patients with a CNS damage, e.g. after an SCI. 
 
 Promises 
- Locomotor treadmill training was introduced into the clinic 25 years ago, originally based on cat 
experiments.
18
 Subsequent human experiments showed that specific physiological receptor 
activation, such as load and hip joint related receptors, is required during such a training to 
achieve a physiological leg muscle activity and, consequently, an improved locomotor function.
43
 
Optimal protocols for the duration of locomotor training, the distribution over the training day, the 
degree of progressive loading and additional physiological parameters are still required. 
 
- Locomotor training on the treadmill is physically exhausting and requires the assistance of 
usually two physiotherapists and is therefore limited in time. Consequently, the idea came up to 
replace the manual by a robotic assistance. The prototype ‘Lokomat’ was designed by Gery 
Colombo in the research lab of the Spinal Cord Injury Center in Zürich (for review 
44
 ) and 
subsequently improved and brought to market by the company Hocoma. Together with an upper 
limb training device of a group at MIT, these training robots triggered the development of robot 
assisted rehabilitation. New generations of these training robots include feedback controlled assist-
as-needed systems and virtual reality set-ups to optimally motivate the patients. SCI, stroke, 
Parkinson’s disease and pediatric brain damage are interesting fields of application of this 
technology. Today besides the Lokomat several exoskeletons are available to assist stepping 
movements but require more input from the patient 
45
Still, however, several questions arise that 
can only be answered by human experiments: (i) What is the optimal approach and what are the 
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limits to exploit neuroplasticity by such devices. (ii) What are the best cues to enhance training 
effects (e.g. movement velocity, duration of training). Presently such information is not available.  
 
-Questions such as individual limits of recovery of function due to neuroplasticity can hardly be 
answered from animal experiments. Robot assisted functional movements have to be designed on 
the basis of physiological requirements (e.g. activation of specific relevant receptors) in order to 
achieve an appropriate limb muscle activation and, consequently, to become beneficial. This 
requires a close cooperation of engineers with basic and clinical scientists. 
 
-The effect of virtual reality in the training of functional movements: Only a few studies exist on 
the effects of a non-motivating vs. a highly motivating virtual reality set-up combined with robot-
assisted rehabilitation programs.
46
 
 
-The effect of specific neural mechanisms underlying physiological hand movements: It could be 
shown by electrophysiological and imaging studies that a task-specific neural coupling mechanism 
underlies cooperative (e.g. opening a bottle) compared to bimanual separate hand movements.  
This coupling is reflected in an involvement of both hemispheres in the control of each hand.
41
 
Consequently, after a cervical SCI or a stroke both hemispheres become involved in the control of 
the paretic hands during such cooperative movements.
47
 For the rehabilitation of upper limb 
movements this has the consequence that a training of cooperative hand movements required 
during a number of daily life activities, eventually in combination with an exclusive training of the 
affected arm/hand (Constraint Induced Movement Therapy) can improve outcome of hand 
function in subjects suffering a CNS damage. 
47
  
 
Challenges 
 Page 10 of 18
Jo
ur
na
l o
f N
eu
ro
tra
um
a
Fr
om
 th
e 
ro
de
nt
 sp
in
al
 c
or
d 
in
jur
y m
od
el 
to 
hu
ma
n a
pp
lic
ati
on
: P
rom
ise
s a
nd
 ch
all
en
ge
s (
do
i: 1
0.1
08
9/n
eu
.20
16
.45
13
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
11 
11 
 
-The observations made on the neuronal mechanisms underlying functional movement disorders 
have to a large part remain phenomenological. Basic animal experiments are required to get 
insight into neuronal mechanisms and pathways involved and to prove their specific contributions 
to a lesion-induced deficit and/or recovery process. 
 
-In human studies no direct access is possible to spinal and supraspinal neuronal mechanisms 
underlying, for example, the development of pain after an SCI. Animal models in different species 
that allow cellular and neuronal circuitry-based insights but also translation to the human level are 
needed. 
 
- For most interventions, such as repair strategies, clinical trials can only be initiated after careful 
and extensive preclinical studies which reduce the risk of adverse side effects to a minimum. A 
direct application of a novel intervention to humans is rarely possible. Such preclinical studies are 
usually costly, require certified good laboratory practice (GLP) and, therefore, often exceed the 
capabilities of academic laboratories. Such hurdles have often been responsible for the slow pace 
of translation from bench to bedside, also in the SCI field. 
 
Conclusions 
 
Novel technological or pharmacological approaches to exploit and enhance neuroplasticity and 
regeneration potential of the nervous system have to be developed in a close, multi-way 
interaction between basic and clinical neuroscientists, occupational and physiotherapists as well as 
engineers. These cooperations can and have to become optimized in the field of SCI research to 
accelerate translations of novel basic animal and human science concepts into therapies for the 
benefit of the spinal cord injured patients. 
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Epilogue  
VD (neurologist, former head of the University of Zurich Spinal Cord Injury Center) and MES 
(neurobiologist) conducted joint research projects over more than 20 years in Zürich (ETH and 
University). This included a translational study of spinal cord regeneration (Nogo-A antibody 
phase 1 study) from the rodent model (MS) to human SCI (VD). We are convinced that only by a 
close cooperation between basic and clinical scientists basic research achievements can 
successfully be translated to the human condition. 
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